LAKE FOREST, Ill. and LAKE BLUFF, Ill., Nov. 16 Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, and Academic Pharmaceuticals, Inc (API), a research and development company specializing in cardiovascular products, announced today that Sotalol Hydrochloride (HCl) Injection for intravenous use is now available. Sotalol Hydrochloride tablets are currently available under the brand name BetapaceŽ.
Bioniche Pharma and API entered into an agreement whereby API developed and secured the FDA approval of Sotalol HCl Injection and Bioniche Pharma maintains the exclusive rights to manufacture, market, and distribute the product in the United States.
"Bioniche Pharma is very pleased to launch Sotalol HCl Injection," said George Zorich, President, US Operations for Bioniche Pharma. "We partnered with API due to their knowledge of anti-arrhythmic treatment options and patient needs. This product expands Bioniche Pharma's growing portfolio of branded products and demonstrates our commitment to aggressively expanding our product line."
Sotalol HCl Injection is currently available and Bioniche Pharma will be attending the November
American Heart Association meeting in Orlando, Florida as part of their introduction of the product.
Sotalol HCl Injection has a black box warning relating to life threatening proarrhythmia. Please refer to
the Bioniche Pharma website for the complete prescribing information, including the boxed warning.
About Bioniche Pharma:
Bioniche Pharma is a global manufacturer of injectable pharmaceutical products serving a variety of niche markets, with expertise in injectable hyaluronic acid products for use in orthopedics, rheumatology, urology, and dermatology. An internal development pipeline and an aggressive acquisition strategy for products fuel the company's growth. RoundTable Healthcare Partners, a private equity firm based in Lake Forest, Illinois, acquired Bioniche Pharma in February 2006. More information about Bioniche Pharma can be found at www.bionichepharma.com.
About Academic Pharmaceuticals, Inc.:
Academic Pharmaceuticals Inc is a Research and Development company specializing in Cardiovascular products. The company specializes in developing anti-arrhythmic parenteral compounds and other cardiovascular drugs that are needed by practicing cardiologists or emergency room physicians. Many of the products in development are orphan drugs that serve specialized populations. The company's expertise is in solubilization of insoluble compounds and designing expedited clinical development and regulatory review programs. The company offices are in Lake Bluff, Illinois.
BetapaceŽ is a registered trademark of Bayer Schering Pharma.
SOURCE Bioniche Pharma